Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04796506 · ClinicalTrials.gov registry record · NA

Slow Wave Sleep As a Biomarker of Rehabilitation-induced Cognitive Improvement in PD

A NA study of Parkinson Disease, sponsored by University of Colorado, Denver.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT04796506 is a NA study of Parkinson Disease that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 120 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04796506, a NA study of Parkinson Disease, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the effects of exercise rehabilitation on cognition and to evaluate slow wave sleep (SWS) as a biomarker and mediator of response to rehabilitation-induced improvement in cognitive performance among persons with Parkinson's disease (PwP), with the ultimate goal of maximizing rehabilitation efficacy at the individual level (i.e. precision rehabilitation).

Conditions Studied

Interventions

  • OTHER Progressive Resistance Training (PRT)
  • OTHER Delayed Exercise Training (DE)
  • OTHER Endurance Training (ET)

Study Locations (1)

Colorado

  • University of Colorado, Anschutz Medical Campus - Aurora

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2021-07-01
Est. Completion 2026-03-31
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT04796506

The ClinicalTrials.gov registry entry for NCT04796506 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 3 interventions - of which Progressive Resistance Training (PRT) is the first listed.

NCT04796506 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT04796506 about?

NCT04796506 is a clinical study titled "Slow Wave Sleep As a Biomarker of Rehabilitation-induced Cognitive Improvement in PD". The purpose of this study is to investigate the effects of exercise rehabilitation on cognition and to evaluate slow wave sleep (SWS) as a biomarker and mediator of response to rehabilitation-induced improvement in cognitive performance among persons with Parkinson's disease (PwP), with the ultimate...

What is the current status of trial NCT04796506?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2021-07-01. Estimated completion is 2026-03-31.

What conditions does trial NCT04796506 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT04796506?

The interventions under investigation include: Progressive Resistance Training (PRT) (OTHER), Delayed Exercise Training (DE) (OTHER), Endurance Training (ET) (OTHER).

Who is sponsoring clinical trial NCT04796506?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04796506 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.